ClinicalTrials.Veeva

Menu

Multicenter Study to Evaluate a Systematized Communication Model for Breast Cancer Patients

M

Medicos e Investigadores en la Lucha contra el Cancer de Mama

Status

Completed

Conditions

Breast Cancer Stage IV
Breast Cancer Metastatic
Communication

Treatments

Other: Communication model

Study type

Interventional

Funder types

Other

Identifiers

NCT05837533
EC-COMUNICACION

Details and patient eligibility

About

Both in Mexico and in the world, breast cancer is the most common malignancy in women. It is estimated that in 2020, 28.2% of the new cancer cases reported in our country correspond to breast cancer, which translates to 30,000 new cases. In addition, it is relevant to mention that approximately 12% of Mexican patients are diagnosed with stage IV breast cancer and it is estimated that 20-30% of women with early stage cancer will have a distant recurrence of the disease. Thus, about 40% of patients will find themselves in a metastatic stage at some point in their breast cancer journey.

Various studies, including Mexico, report that only half of patients with metastatic breast cancer are aware that their disease is not curable, 31% say they are not sure, and 17% think it is curable. Likewise, 58% considered that they did not have enough knowledge to actively participate in conversations about their therapeutic options, which means that 40% reported difficulty talking about treatments with their doctors. This has shown that there are suboptimal levels of knowledge information on curability, treatment objectives and prognosis of their condition in patients with metastatic breast cancer. This lack of understanding is alarming given that a general understanding of the disease is crucial for informed decision making and adherence to cancer treatment.

Due to these alarming results, we seek to recruit women ≥18 years of age who are candidates to start first- or second-line treatment for de novo or recurrent metastatic breast cancer from various hospital centers in the country with public and private coverage, including Hospital Zambrano Hellion TecSalud as coordinating center in Nuevo León. The objective will be to evaluate whether a systematized communication model for patients with metastatic breast cancer allows increasing knowledge about the non-curative nature of treatment, compared to usual care.

Enrollment

100 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of de novo or recurrent metastatic breast cancer
  • Candidate to start the first or second line of treatment for metastatic breast cancer

Exclusion criteria

  • Receipt of a line of treatment for metastatic breast cancer posterior to the second line

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Sequential Assignment

Masking

Double Blind

100 participants in 2 patient groups

Intervention group
Experimental group
Description:
Patients will receive information about their diagnosis, treatment and/or prognosis through the systematic communication model under study used by their oncologist during their medical consultation.
Treatment:
Other: Communication model
Control group
No Intervention group
Description:
Patients will receive information about their diagnosis, treatment and/or prognosis through their usual care provided by their oncologist during their medical consultation.

Trial contacts and locations

1

Loading...

Central trial contact

Cynthia Villarreal-Garza, MD, DSc; Fernanda Mesa Chavez, MD, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems